Vincent van der Noort - Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 20 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Table S1 from the Innate Immune Landscape of Dmmr/msi Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol

Laurien J. Zeverijn,Birgit S. Geurts,Thomas W. Battaglia, Jade M. van Berge Henegouwen,Gijs F. de Wit,Louisa R. Hoes,Hanneke van der Wijngaart,Vincent van der Noort,Paul Roepman, Wendy W.J. de Leng,Anne M.L. Jansen, Myriam Chalabi,Carla M.L. van Herpen,Lot A. Devriese,Frans L.G. Erdkamp,Mariette Labots,Maja J.A. de Jonge,Emile D. Kerver,Adriaan D. Bins, Lindsay V.M. Leek, Jessica C.L. Notohardjo, Alfonsus J.M. van den Eertwegh,Lodewyk F.A. Wessels,Henk M.W. Verheul,Hans Gelderblom,Joris van de Haar,Emile E. Voest

crossref（2024）

Cited0Views0Bibtex

Supplementary Table S1 from Maximizing Treatment Opportunities: Assessing Protocol Waivers’ Impact on Safety and Outcome in the Drug Rediscovery Protocol

Jade M. van Berge Henegouwen,Laurien J. Zeverijn,Birgit S. Geurts,Louisa R. Hoes,Hanneke van der Wijngaart,Vincent van der Noort,Alwin D.R. Huitema,Filip Y.F. de Vos,Katrien Grünberg,Haiko J. Bloemendal,Henk M.W. Verheul,Emile E. Voest,Hans Gelderblom

crossref（2024）

Cited0Views0Bibtex

Oncologic Outcome of Response-Guided Axillary Treatment in Patients with Cn1 Breast Cancer after Primary Systemic Therapy

Annemiek van Hemert,Ariane van Loevezijn, Marie-Sophie Baas,Marcel P. Stokkel,Emilie Groen,Vincent van der Noort,Claudette Loo,Gabe S. Sonke,Nicola Russell,Frederieke H. van Duijnhoven,Marie-Jeanne T. F. D. Vrancken Peeters

Journal of Clinical Oncologyno. 16_suppl (2024): 514-514

Cited0Views0Bibtex

Supplementary Table S2 from the Innate Immune Landscape of Dmmr/msi Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S1 from the Innate Immune Landscape of Dmmr/msi Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol

crossref（2024）

Cited0Views0Bibtex

Supplementary Table S6 from the Innate Immune Landscape of Dmmr/msi Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S2 from the Innate Immune Landscape of Dmmr/msi Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol

crossref（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn